Evogene Ltd.
EVGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18 | -$26 | -$30 | -$30 |
| Dep. & Amort. | $3 | $3 | $3 | $2 |
| Deferred Tax | $0 | -$0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $1 | $3 |
| Change in WC | -$3 | -$0 | -$1 | $2 |
| Other Non-Cash | -$3 | $0 | $3 | -$1 |
| Operating Cash Flow | -$20 | -$22 | -$24 | -$25 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$17 | -$11 | -$1 | -$24 |
| Inv. Sales/Matur. | $27 | $7 | $15 | $4 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $10 | -$5 | $13 | -$20 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | $9 | -$1 |
| Stock Issued | $0 | $8 | $0 | $30 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5 | $11 | $0 | $1 |
| Financing Cash Flow | $5 | $18 | $9 | $30 |
| Forex Effect | -$0 | -$0 | -$2 | $1 |
| Net Chg. in Cash | -$5 | -$8 | -$3 | -$14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | $29 | $32 | $46 |
| End Cash | $15 | $21 | $29 | $32 |
| Free Cash Flow | -$20 | -$22 | -$25 | -$26 |